Europe's pharma sector faces increasing challenges

The Wall Street Journal: "After a healthy second quarter, Europe's pharmaceutical sector may find itself in trouble in the months ahead as companies face patent expiries, tougher regulation and burdensome health care reforms. There is no single remedy for these problems, experts say, so companies need to devise individual ways to pump up their product pipeline to boost growth and profits. … While cost-cutting is essential to protect profit margins, experts say drug makers must also revamp their research operations and tap into new disease areas to stay competitive. Emerging markets are now a key focus, too" (Mijuk and Stovall, 8/25).

---

This article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.